logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • Cookie opt-out
  • Cookie opt-out
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Samples
    2. /
    3. Ninlaro
    Oncology

    Ninlaro Samples

    ixazomib

    Manufacturer
    Takeda
    Indication
    Proteasome inhibitor for multiple myeloma
    Restrictions: Oncology specialty required

    How It Works

    1
    Enter your NPI number and email address
    2
    We check your eligibility with Takeda
    3
    Order samples instantly or request access
    Free for healthcare providers
    350K+ providers use PrescriberPoint

    Ninlaro Sample FAQs

    Are Ninlaro samples available for healthcare providers?

    Ninlaro samples may be available through Takeda's patient access programs. Check your eligibility on PrescriberPoint by entering your NPI number to see current availability.

    How do I get free Ninlaro samples?

    To request free Ninlaro (ixazomib) samples, enter your NPI number on PrescriberPoint. We'll instantly verify your eligibility with Takeda and show you how to order samples. The process takes less than a minute and is completely free for licensed prescribers.

    Who is eligible for Ninlaro drug samples?

    Licensed healthcare providers including physicians (MDs, DOs), nurse practitioners, and physician assistants with valid NPI numbers may be eligible for Ninlaro samples. Eligibility is determined by Takeda based on your prescribing credentials and state licensing. PrescriberPoint checks your eligibility instantly.

    How long does it take to receive Ninlaro samples?

    Delivery times for Ninlaro samples from Takeda typically range from 2-4 weeks after your request is approved. Some manufacturers offer expedited shipping. You'll receive confirmation once your samples are processed.

    More from Takeda

    View all
    Vyvanse
    lisdexamfetamine dimesylate
    Psychiatry
    Entyvio
    vedolizumab
    Gastroenterology
    Trintellix
    vortioxetine
    Psychiatry
    Takhzyro
    lanadelumab-flyo
    Rare Disease

    More Oncology Samples

    View all
    Keytruda
    pembrolizumab
    Merck
    Tecentriq
    atezolizumab
    Genentech (Roche)
    Darzalex
    daratumumab
    Janssen (J&J)
    Tagrisso
    osimertinib
    AstraZeneca
    Herceptin
    trastuzumab
    Genentech (Roche)
    Ibrance
    palbociclib
    Pfizer

    Popular Samples

    Browse all
    Ozempic
    semaglutide injection
    Novo Nordisk
    Diabetes
    Eliquis
    apixaban
    Pfizer
    Cardiovascular
    Dupixent
    dupilumab
    Sanofi
    Immunology
    Eylea
    aflibercept
    Regeneron
    Ophthalmology
    Xarelto
    rivaroxaban
    Janssen (J&J)
    Cardiovascular
    Entresto
    sacubitril/valsartan
    Novartis
    Cardiovascular
    105+
    Products Available
    50+
    Manufacturers
    20+
    Therapeutic Areas